Advertisement
Canada markets close in 4 hours 57 minutes

  • S&P/TSX

    21,746.54
    -127.18 (-0.58%)
     

  • S&P 500

    5,005.13
    -66.50 (-1.31%)
     

  • DOW

    37,804.59
    -656.33 (-1.71%)
     

  • CAD/USD

    0.7296
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    82.11
    -0.70 (-0.85%)
     

  • Bitcoin CAD

    86,947.93
    -2,396.11 (-2.68%)
     

  • CMC Crypto 200

    1,373.46
    -9.12 (-0.66%)
     

  • GOLD FUTURES

    2,348.80
    +10.40 (+0.44%)
     

  • RUSSELL 2000

    1,966.39
    -29.03 (-1.46%)
     

  • 10-Yr Bond

    4.7120
    +0.0600 (+1.29%)
     

  • NASDAQ

    15,453.84
    -258.91 (-1.65%)
     

  • VOLATILITY

    17.05
    +1.08 (+6.76%)
     

  • FTSE

    8,062.65
    +22.27 (+0.28%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6808
    -0.0011 (-0.16%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Today’s Research Reports on Emblem, 3D Signatures, ABcann Global and Theralase Technologies Inc.

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 19, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Emblem Corp.
https://rdinvesting.com/news/?ticker=EMC.V

3D Signatures Inc.
https://rdinvesting.com/news/?ticker=DXD.V

ABcann Global Corporation
https://rdinvesting.com/news/?ticker=ABCN.V

Theralase Technologies Inc.
https://rdinvesting.com/news/?ticker=TLT.V

ADVERTISEMENT

Emblem's stock moved 2.10% higher Friday, to close the day at $1.46. The stock recorded a trading volume of 331,384 shares, which was below its three months average volume of 1,314,468 shares. In the last year, Emblem's shares have traded in a range of 1.36 - 26.32. The stock is currently trading 94.45% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.58 is below its 200-day moving average of $1.77. Shares of Emblem have fallen approximately 39.67 percent year-to-date.

Access RDI's Emblem Corp. Research Report at:
https://rdinvesting.com/news/?ticker=EMC.V

On Friday, shares of 3D Signatures recorded a trading volume of 38,792 shares, which was below the three months average volume of 87,433 shares. The stock ended the day 6.15% higher at 0.34. The share price has gained 86.49% from its 52-week low with a 52-week trading range of 0.19 - 0.87. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.30 is greater than its 200-day moving average of $0.26. Shares of 3D Signatures have gained approximately 30.19 percent year-to-date.

Access RDI's 3D Signatures Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DXD.V

ABcann Global's stock jumped 6.70% Friday, to close the day at $2.23. The stock recorded a trading volume of 1,652,764 shares, which was below its three months average volume of 2,635,050 shares. In the last year, ABcann Global's shares have traded in a range of 0.80 - 4.06. The share price has gained 178.75% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.37 is greater than its 200-day moving average of $1.66. Shares of ABcann Global have gained approximately 19.89 percent year-to-date.

Access RDI's ABcann Global Corporation Research Report at:
https://rdinvesting.com/news/?ticker=ABCN.V

On Friday, shares of Theralase Technologies recorded a trading volume of 64,800 shares, which was below the three months average volume of 201,098 shares. The stock ended the day flat at 0.23. The share price has gained 21.05% from its 52-week low with a 52-week trading range of 0.19 - 0.55. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.22 is below its 200-day moving average of $0.32. Shares of Theralase Technologies have fallen approximately 4.17 percent year-to-date.

Access RDI's Theralase Technologies Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TLT.V

Our Actionable Research on Emblem Corp. (TSXV:EMC.V), 3D Signatures Inc. (TSXV:DXD.V), ABcann Global Corporation (TSXV:ABCN.V) and Theralase Technologies Inc. (TSXV:TLT.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com